Privia Health Group Inc

Privia Health's second quarter results were met with a negative market reaction as investors digested the company's strong revenue growth alongside a material shortfall in non-GAAP profit relative to Wall Street expectations. Revenue came in at $632.6 million versus analyst estimates of $597.2 million, a 21.4% year-on-year increase and a 5.9% beat, while adjusted EPS of $0.19 missed analyst expectations of $0.24 by 22.2%. Adjusted EBITDA was $37.43 million versus estimates of $36.88 million, and operating margin improved to 1.9% from 0.6% a year earlier. During the earnings call, analysts questioned management on delayed CMS shared savings payments, confidence in reaching the high end of long-term EBITDA margin targets, deceleration in second-half practice collections growth, AI use cases, and integration of the Evolent and IMS acquisitions. CEO Parth Mehrotra described the guidance as prudent and highlighted AI deployment across corporate and care workflows, while CFO David Mountcastle pointed to operational leverage and market maturity as margin drivers.

StockStory highlights SEI Investments as a cash-heavy stock to buy this week while recommending investors avoid Privia Health and Hamilton Insurance Group. SEI Investments holds a net cash position of $343 million, representing 2.9% of its market cap, and has posted annual revenue growth of 9.9% over the last two years along with a 26.5% return on equity. Privia Health, with a net cash position of $410.5 million or 11.6% of its market cap, is flagged for its modest $2.25 billion revenue base, 5% free cash flow margin, and 0% return on capital. Hamilton Insurance Group carries a net cash position of $805.7 million, equal to 24.1% of its market cap, but faces flat projected sales and earnings per share growth of 14% that lagged its revenue gains.

Former Privia Health Group CEO Shawn Morris sold 135,498 shares for approximately $3.6 million through an exercise-and-immediate-sale of stock options, according to an SEC filing. The transactions, executed at a weighted average price of $26.32 on June 30 and July 1, were part of a pre-arranged Rule 10b5-1 trading plan and occurred just days before his retirement from the Board of Directors on July 6. The sale reduced Morris' direct common share position by nearly 64%, though he retains 76,651 directly-held shares, millions of fully-vested stock options, and over 24,000 shares held indirectly. Privia Health shares closed at $26.88 on July 1, up 19.3% over the trailing year, and later hit a 52-week high of $27.86 on July 10 following strong first-quarter sales growth of nearly 26% year over year to $603.8 million and an expansion into New Jersey.